White matter hyperintensities in mild lewy body dementia

K Oppedal1, D Aarsland, M J Firbank

  • 1Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway ; Department of Electrical Engineering and Computer Science, University of Stavanger, Stavanger, Norway.

Abstract

Insights

White matter hyperintensities (WMH) loads were similar in Lewy body dementia (LBD) and Alzheimer's disease (AD). Cognitive function correlated with WMH in AD, but not in LBD patients, suggesting different disease mechanisms.

Area of Science:

  • Neuroimaging
  • Neurology
  • Vascular Dementia

Background:

  • White matter hyperintensities (WMH) are common in neurodegenerative diseases.
  • Understanding WMH load differences between Lewy body dementia (LBD) and Alzheimer's disease (AD) is crucial for diagnosis and treatment.
  • Comparing WMH in LBD, AD, and normal controls (NC) provides insights into disease-specific pathologies.

Purpose of the Study:

  • To quantify and compare the burden of white matter hyperintensities (WMH) in patients diagnosed with Lewy body dementia (LBD).
  • To compare WMH load in LBD patients against those with Alzheimer's disease (AD) and normal elderly controls (NC).
  • To investigate the relationship between WMH load and cognitive performance in LBD and AD.

Main Methods:

  • Diagnosis of LBD and AD was confirmed using consensus criteria and cognitive assessments.
  • Magnetic Resonance Imaging (MRI) FLAIR sequences were used to segment and quantify WMH volumes across brain regions.
  • Non-parametric tests and multivariate regression analyses were employed to compare WMH loads and their association with cognitive scores across patient groups.

Main Results:

  • No significant differences in overall WMH load were observed between patients with LBD and AD.
  • A significant correlation between WMH volume (total and frontal) and cognitive scores (MMSE, verbal fluency) was found in the AD group.
  • This correlation between WMH and cognition was not significant in the LBD group.

Conclusions:

  • The burden of white matter hyperintensities (WMH) in Lewy body dementia (LBD) is comparable to that observed in Alzheimer's disease (AD).
  • Cognitive impairment in AD is associated with WMH, suggesting a contribution of vascular factors.
  • The lack of correlation between WMH and cognition in LBD indicates that vascular disease may not be a primary driver of cognitive decline in this condition, unlike in AD.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.